NIH-funded research R01 grant

Understanding how signals affect nerve cell development and degeneration.

Official title: Long distance regressive signaling underlies sculpting of the nervous system during development.

Funded at Vanderbilt University · NIH-11047331 · Data updated 2026-11-12

This study is looking at how certain signals in the nervous system can cause nerve cells to die, which might help us understand conditions like autism and Alzheimer's disease better, and it could lead to new ways to treat these issues.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVanderbilt University
NIH-funded
Lab location1 site (Nashville, UNITED STATES)
Project startJanuary 1, 2025
Project endDecember 31, 2029
Funding year2025
Award (this year)$543,337
NIH project number1R01NS136342-01A1
Project IDNIH-11047331 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with neurodevelopmental disorders like autism or neurodegenerative diseases such as Alzheimer's or ALS.

Less likely to help

Patients with acute neurological injuries or those not diagnosed with the targeted neurodevelopmental or neurodegenerative conditions may not benefit from this research.

What this research studies

This research investigates the mechanisms of long-distance signaling in the nervous system, focusing on how certain signals can lead to nerve cell death and degeneration. By studying the p75 neurotrophin receptor, the research aims to uncover how these signals are transmitted from nerve endings back to the cell body. This could provide insights into various neurodevelopmental and neurodegenerative disorders, including autism and Alzheimer's disease. The approach involves examining the molecular processes that regulate these signaling pathways, which could lead to new therapeutic strategies.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for neurodevelopmental and neurodegenerative disorders.

How similar studies have gone: Previous research has shown promising results in understanding similar signaling pathways, indicating potential for success in this area.

Where this research is happening

  • Vanderbilt University
    Nashville, United States
    Active

Researchers

  • Principal investigator: Carter, Bruce D — Vanderbilt University
  • Study coordinator: Carter, Bruce D

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.